Documents by Year
1930s (3)
1940s (7)
1950s (5)
1960s (6)
1970s (68)
1980s (275)
1990s (122)
2000s (15)
2010s (1108)
2020s (1)

Other RB norms

GF RB 01/2013:20519
GF RB 01/2013:20519
2.5.19. O-acetyl in polysaccharide vaccines
GF RB 01/2013:20520
GF RB 01/2013:20520
2.5.20. Hexosamines in polysaccharide vaccines
GF RB 01/2013:20521
GF RB 01/2013:20521
2.5.21. Methylpentoses in polysaccharide vaccines
GF RB 01/2013:20522
GF RB 01/2013:20522
2.5.22. Uronic acids in polysaccharide vaccines
GF RB 01/2013:20523
GF RB 01/2013:20523
2.5.23. Sialic acid in polysaccharide vaccines
GF RB 01/2013:20524
GF RB 01/2013:20524
2.5.24. Carbon dioxide in gases
GF RB 01/2013:20525
GF RB 01/2013:20525
2.5.25. Carbon monoxide in gases
GF RB 01/2013:20526
GF RB 01/2013:20526
2.5.26. Nitrogen monoxide and nitrogen dioxide in gases
GF RB 01/2013:20527
GF RB 01/2013:20527
2.5.27. Oxygen in gases
GF RB 01/2013:20528
GF RB 01/2013:20528
2.5.28. Water in gases
GF RB 01/2013:20529
GF RB 01/2013:20529
2.5.29. Sulfur dioxide
GF RB 01/2013:20530
GF RB 01/2013:20530
2.5.30. Oxidizing agents
GF RB 01/2013:20531
GF RB 01/2013:20531
2.5.31. Ribose in polysaccharide vaccines
GF RB 01/2013:20532
GF RB 01/2013:20532
2.5.32. Water: microdetermination
GF RB 01/2013:20533
GF RB 01/2013:20533
2.5.33. Total protein
GF RB 01/2013:20534
GF RB 01/2013:20534
2.5.34. Acetic acid in synthetic peptides
GF RB 01/2013:20535
GF RB 01/2013:20535
2.5.35. Nitrous oxide in gases
GF RB 01/2013:20536
GF RB 01/2013:20536
2.5.36. Anisidine number
GF RB 01/2013:20537
GF RB 01/2013:20537
2.5.37. Methyl, ethyl and isopropyl methanesulfonate in methanesulfonic acid
GF RB 01/2013:20538
GF RB 01/2013:20538
2.5.38. Methyl, ethyl and isopropyl methanesulfonate in pharmaceutical substances
GF RB 01/2013:20539
GF RB 01/2013:20539
2.5.39. Methanesulfonyl chloride in methanesulfonic acid
GF RB 01/2013:20601
GF RB 01/2013:20601
2.6.1. Sterility
GF RB 01/2013:20602
GF RB 01/2013:20602
2.6.2. Mycobacteria
GF RB 01/2013:20607
GF RB 01/2013:20607
2.6.7. Mycoplasma
GF RB 01/2013:20608
GF RB 01/2013:20608
2.6.8. Pyrogenicity
GF RB 01/2013:20609
GF RB 01/2013:20609
2.6.9. Abnormal toxicity
GF RB 01/2013:20610
GF RB 01/2013:20610
2.6.10. Histamine
GF RB 01/2013:20611
GF RB 01/2013:20611
2.6.11. Depressor substances
GF RB 01/2013:20612
GF RB 01/2013:20612
2.6.12. Microbiological testing of non-sterile products: total viable aerobes
GF RB 01/2013:20614
GF RB 01/2013:20614
2.6.14. Bacterial endotoxins
GF RB 01/2013:20615
GF RB 01/2013:20615
2.6.15. Prekallikrein activator
GF RB 01/2013:20616
GF RB 01/2013:20616
2.6.16. Testing for foreign agents in viral vaccines for medical use
GF RB 01/2013:20617
GF RB 01/2013:20617
2.6.17. The test for anti-complementary activity of immunoglobulin
GF RB 01/2013:20618
GF RB 01/2013:20618
2.6.18. Test of live viral vaccines for neurovirulence
GF RB 01/2013:20619
GF RB 01/2013:20619
2.6.19. Test of oral polio vaccine for neurovirulence
GF RB 01/2013:20620
GF RB 01/2013:20620
2.6.20. Anti-A and anti-B hemagglutinins (indirect method)
GF RB 01/2013:20621
GF RB 01/2013:20621
2.6.21. Nucleic Acid Amplification Methods
GF RB 01/2013:20622
GF RB 01/2013:20622
2.6.22. Activated blood coagulation factors
GF RB 01/2013:20626
GF RB 01/2013:20626
2.6.26. Test for anti-D antibodies in human immunoglobulin for intravenous administration
GF RB 01/2013:20627
GF RB 01/2013:20627
2.6.27. Microbiological control of cellular products
GF RB 01/2013:20630
GF RB 01/2013:20630
2.6.30. Monocyte Activation Test
GF RB 01/2013:20701
GF RB 01/2013:20701
2.7.1. Immunochemical methods
GF RB 01/2013:20702
GF RB 01/2013:20702
2.7.2. Quantitative determination of antibiotics by microbiological method
GF RB 01/2013:20704
GF RB 01/2013:20704
2.7.4. Quantitative determination of coagulation factor VIII
GF RB 01/2013:20705
GF RB 01/2013:20705
2.7.5. Quantitative determination of heparin
GF RB 01/2013:20706
GF RB 01/2013:20706
2.7.6. Quantitative determination of the adsorbed diphtheria vaccine
GF RB 01/2013:20707
GF RB 01/2013:20707
2.7.7. Quantitative determination of pertussis vaccine
GF RB 01/2013:20708
GF RB 01/2013:20708
2.7.8. Quantitative determination of the adsorbed tetanus vaccine

All Codes and Regulations

GOST RB PUE RB Decrees RB Letters SNB RB TR EAES
MSP RB Codes RB Instructions RB Orders STB RB
Other RB norms RB Decisions RB Laws RB Resolutions TKP

All Categories

Construction (Max) Highways (Max) National Standards for KGS (State Standards Classification) Projects of works (PPR) on bridges Technical Supervision
Construction Price Formation ISO classifier Organization Standards PromExpert Welding regulations
Evidence base (TR CU, Technical Regulation of the Customs Union) National standards Power industry Standards for pipe fittings (TPA)

Send us a message Expand Collapse

Leave your message in the form below, and we will write back by e-mail!